CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger ...
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
- Record
CVE-2015-3965- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 9.0 High
AV:N/AC:L/Au:S/C:C/I:C/A:C - Weakness
- CWE-264
- Updated
- 2026-11-02
CVE List No score
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
- Record
CVE-2015-3965- Updated
- 2026-11-02
EUVDEUVD-2015-3996 No score
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
- Record
EUVD-2015-3996- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-fw6x-q668-xp72
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger ...
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
- Record
GHSA-fw6x-q668-xp72- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2015-3965 is a high vulnerability (CVSS 8.8) in Hospira Symbiq Infusion System, published March 23, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.88%, the 86th percentile. No source names a fixed version.